Verona Pharma plc (VRNA) — Analyst outlook / Analyst consensus target is. Based on 14 analyst ratings, the consensus is bullish — 9 Buy, 5 Hold.
The consensus price target is $107.00 (low: $74.00, high: $170.00), representing an upside of 0.1% from the current price $106.91.
VRNA Stock — 12-Month Price Forecast
$107.00
▲ +0.08% Upside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for Verona Pharma plc, the average price target is $107.00, with a high forecast of $170.00, and a low forecast of $74.00.
The average price target represents a +0.08% change from the last price of $106.91.
Highest Price Target
$170.00
Average Price Target
$107.00
Lowest Price Target
$74.00
VRNA Analyst Ratings
Buy
Based on 14 analysts giving stock ratings to Verona Pharma plc in the past 3 months
